Halloysite nanotubes-carbon dots hybrids multifunctional nanocarrier with positive cell target ability as a potential non-viral vector for oral gene therapy.


Journal

Journal of colloid and interface science
ISSN: 1095-7103
Titre abrégé: J Colloid Interface Sci
Pays: United States
ID NLM: 0043125

Informations de publication

Date de publication:
15 Sep 2019
Historique:
received: 18 03 2019
revised: 10 05 2019
accepted: 19 05 2019
pubmed: 28 5 2019
medline: 19 2 2020
entrez: 27 5 2019
Statut: ppublish

Résumé

The use of non-viral vectors for gene therapy is hindered by their lower transfection efficiency and their lacking of self-track ability. This study aims to investigate the biological properties of halloysite nanotubes-carbon dots hybrid and its potential use as non-viral vector for oral gene therapy. The morphology and the chemical composition of the halloysite hybrid were investigated by means of high angle annular dark field scanning TEM and electron energy loss spectroscopy techniques, respectively. The cytotoxicity and the antioxidant activity were investigated by standard methods (MTS, DPPH and H All investigations performed confirmed the existence of strong electrostatic interactions between the DNA and the halloysite hybrid, so it shows promise as a multi-functional cationic non-viral vector that has also possesses intracellular tracking capability and promising in vitro antioxidant potential.

Identifiants

pubmed: 31129295
pii: S0021-9797(19)30614-9
doi: 10.1016/j.jcis.2019.05.062
pii:
doi:

Substances chimiques

Antioxidants 0
Drug Carriers 0
Nanotubes, Carbon 0
DNA 9007-49-2
calf thymus DNA 91080-16-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

236-246

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Marina Massaro (M)

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.

Giampaolo Barone (G)

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.

Giuseppa Biddeci (G)

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy; Institute of Biomedicine and Molecular Immunology, CNR, IBIM, Via Ugo La Malfa, 153, 90146 Palermo, Italy.

Giuseppe Cavallaro (G)

Dipartimento di Fisica e Chimica (DiFC), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.

Francesco Di Blasi (F)

Institute of Biomedicine and Molecular Immunology, CNR, IBIM, Via Ugo La Malfa, 153, 90146 Palermo, Italy.

Giuseppe Lazzara (G)

Dipartimento di Fisica e Chimica (DiFC), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy.

Giuseppe Nicotra (G)

CNR-IMM, Zona Industriale Strada VIII, 5, 95121 Catania, Italy.

Corrado Spinella (C)

CNR-IMM, Zona Industriale Strada VIII, 5, 95121 Catania, Italy.

Gaetano Spinelli (G)

Institute of Biomedicine and Molecular Immunology, CNR, IBIM, Via Ugo La Malfa, 153, 90146 Palermo, Italy.

Serena Riela (S)

Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), University of Palermo, Viale delle Scienze, Ed. 17, 90128 Palermo, Italy. Electronic address: serena.riela@unipa.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH